Thoracic Neoplasms
Information
- Disease name
- Thoracic Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04222972 | Active, not recruiting | Phase 3 | A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) | July 24, 2020 | June 30, 2025 |
| NCT04862780 | Active, not recruiting | Phase 1/Phase 2 | (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC | June 29, 2021 | January 31, 2025 |
| NCT02871856 | Active, not recruiting | N/A | International Lung Screen Trial (ILST) | April 5, 2017 | December 2025 |
| NCT04589247 | Active, not recruiting | Improving Cancer Symptom Management | November 16, 2020 | June 2025 | |
| NCT04227717 | Active, not recruiting | Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine | January 9, 2020 | January 9, 2025 | |
| NCT01024413 | Completed | Phase 3 | Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations | July 2009 | June 2015 |
| NCT05770869 | Completed | N/A | mHealth ALIBIRD: A Digital Health Care Model | November 5, 2021 | October 28, 2022 |
| NCT03134872 | Completed | Phase 3 | A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC | May 12, 2017 | August 29, 2019 |
| NCT02188563 | Completed | N/A | A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers | May 2014 | May 2016 |
| NCT04751552 | Completed | N/A | Erector Spinae Block for Thoracoscopic Surgery | October 21, 2020 | September 2, 2023 |
| NCT04741958 | Completed | N/A | Role of Ultrasound Guided Peripheral Thoracic Tumors | September 12, 2020 | December 1, 2020 |
| NCT02897778 | Completed | Phase 1 | Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors | August 24, 2016 | March 13, 2017 |
| NCT02909452 | Completed | Phase 1 | Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors | September 20, 2016 | February 9, 2021 |
| NCT03037385 | Completed | Phase 1/Phase 2 | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors | March 17, 2017 | March 21, 2024 |
| NCT00437372 | Completed | Phase 1 | Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients | March 2007 | December 2010 |
| NCT00591981 | Completed | Thoracic OncoGeriatric Assessment (TOGA) Trials | August 2007 | August 2012 | |
| NCT00213603 | Completed | Follow-up Modalities of Low Grade Precancerous Bronchial Lesions | April 2002 | November 2009 | |
| NCT00880971 | Completed | Phase 3 | Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer | February 18, 2009 | February 29, 2020 |
| NCT06376084 | Not yet recruiting | Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC | July 24, 2024 | February 28, 2028 | |
| NCT06104774 | Not yet recruiting | N/A | The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic Surgery | October 20, 2023 | July 31, 2025 |
| NCT04776447 | Recruiting | Phase 2 | Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) | June 16, 2021 | November 15, 2027 |
| NCT05993273 | Recruiting | N/A | Pain Control After VATS Anatomical Pulmonary Resections | April 5, 2023 | April 15, 2025 |
| NCT06004440 | Recruiting | Real World Registry for Use of the Ion Endoluminal System | September 21, 2023 | August 2027 | |
| NCT06177925 | Recruiting | Phase 2 | A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC | December 10, 2023 | September 30, 2026 |
| NCT06335290 | Recruiting | Radiotherapy Treatments for the Treatment of Thoracic District Tumors | February 22, 2018 | December 31, 2024 | |
| NCT05521789 | Recruiting | Phase 4 | Erector Spinae Block for Thoracic Surgery | July 22, 2022 | July 21, 2024 |
| NCT05988736 | Recruiting | N/A | Comparison Between McGrath and Macintosh Laryngoscopes for DLT Intubation in Thoracic Surgery Patients. | June 15, 2022 | December 31, 2023 |
| NCT05153408 | Terminated | Phase 1 | (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC | January 13, 2022 | December 9, 2022 |
| NCT04644315 | Terminated | Phase 2 | A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | May 24, 2021 | May 16, 2022 |
| NCT03306693 | Terminated | N/A | Educational Intervention to Increase the Emotional Competence of Patients With Oesogastric and Bronchopulmonary Cancers | October 26, 2017 | May 7, 2019 |
| NCT02111824 | Terminated | Phase 1 | A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy | January 5, 2014 | November 2019 |
| NCT04133337 | Unknown status | Phase 1/Phase 2 | Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC | November 1, 2019 | June 2021 |
| NCT04235556 | Unknown status | Integrated Care Pathway in Oncology (PASSION) | February 21, 2020 | December 31, 2022 | |
| NCT04371796 | Unknown status | Phase 2 | Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC | May 10, 2020 | December 30, 2021 |
| NCT04556344 | Unknown status | N/A | Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer | October 26, 2020 | October 2023 |
| NCT03389256 | Unknown status | Phase 2 | Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC | December 30, 2018 | August 30, 2022 |
| NCT04697446 | Unknown status | External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC | December 1, 2020 | October 31, 2021 | |
| NCT04725448 | Unknown status | Phase 2 | Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma | April 6, 2021 | November 30, 2023 |
| NCT02833467 | Unknown status | Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA | January 2015 | June 2021 | |
| NCT01913769 | Unknown status | Monitoring Radiobiological Effects in Thoracic Malignancy by Using Myocardial Perfusion Scan | July 2013 | July 2016 | |
| NCT00631839 | Unknown status | Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury | January 2002 | October 2008 | |
| NCT03402048 | Unknown status | Phase 3 | The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial | July 2012 | May 2021 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D013899